Article Information
PubMed
Published By
History
- Received March 4, 2021
- Revision received August 18, 2021
- Accepted August 21, 2021
- Published online August 30, 2021.
Copyright & Usage
Copyright © 2021 Takagishi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Soh Takagishi1,
- Koichi Arimura1,
- Masaharu Murata2,3,
- Katsuma Iwaki1,
- Tomohiro Okuda1,
- Keisuke Ido1,
- Ataru Nishimura1,
- Sayoko Narahara2,
- Takahito Kawano2 and
- Koji Iihara1,4
- 1Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan
- 2Center for Advanced Medical Innovation, Kyushu University, Fukuoka 812-8582, Japan
- 3Department of Advanced Medical Initiatives, Faculty of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan
- 4National Cerebral and Cardiovascular Center, Suita, Japan, Osaka 564-8565, Japan
- Correspondence should be addressed to Koichi Arimura at arimura.koichi.001{at}m.kyushu-u.ac.jp.
Author contributions
Author contributions: S.T., K.A., M.M., A.N., and K.Ii. designed research; S.T., K.Iw., T.O., K.Id., and S.N. performed research; S.T., K.Iw., S.N., and T.K. analyzed data; S.T., K.A., and T.K. wrote the paper.
Disclosures
The authors declare no competing financial interests.
This work was supported by from the Ministry of Education, Culture, Sports, Science and Technology of Japan Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI) 18K16588 (to K.A.), 18K12079 (to T.K.), and 19H04470 (to M.M.) and by a Bristol Myers Squibb Research grant (K.A.).
Funding
JSPS KAKENHI
18K16588; 18K12079; 19H04470Bristol-Myers Squibb (BMS)
Other Version
- You are viewing the most recent version of this article.
- previous version (August 30, 2021).
Online Impact
Article usage
In this issue
Protein Nanoparticles Modified with PDGF-B as a Novel Therapy After Acute Cerebral Infarction
